- Investing Ideas
- U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
11
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
11 companies
Merck
Market Cap: US$271.8b
Operates as a healthcare company worldwide.
MRK
US$110.95
7D
-1.7%
1Y
30.2%
Illumina
Market Cap: US$19.3b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$120.37
7D
-7.8%
1Y
55.1%
Exelixis
Market Cap: US$11.4b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$44.69
7D
-3.0%
1Y
14.9%
ACADIA Pharmaceuticals
Market Cap: US$3.8b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$22.20
7D
0.4%
1Y
52.4%
ADMA Biologics
Market Cap: US$2.5b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$10.60
7D
-4.3%
1Y
-54.4%
Aurinia Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
AUPH
US$15.28
7D
-6.9%
1Y
85.4%
Theravance Biopharma
Market Cap: US$863.0m
A biopharmaceutical company, develops and commercializes medicines in the United States.
TBPH
US$16.67
7D
0.6%
1Y
70.6%
CorMedix
Market Cap: US$593.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.48
7D
-0.1%
1Y
-18.6%
Abeona Therapeutics
Market Cap: US$304.9m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.34
7D
-5.2%
1Y
-18.6%
Compugen
Market Cap: US$245.4m
A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.
CGEN
US$2.60
7D
-11.0%
1Y
71.1%
Oramed Pharmaceuticals
Market Cap: US$155.7m
Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
ORMP
US$3.84
7D
0%
1Y
69.2%